Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Immune Checkpoint Inhibitors × 30 days × Clear all

Phase

Phase 2 8 Phase NA 3 Phase 1 3 Phase 3 2 Phase 1/2 1

Sponsor

Interventions

Specimen Handling 4 Biopsy 4 pembrolizumab 3 Magnetic Resonance Spectroscopy 3 Bevacizumab 3 tremelimumab 2 olaparib 2 encorafenib 2 X-Rays 2 Panitumumab 2 Nivolumab 2 Immunotherapy, Adoptive 2 Immunoglobulin G 2 Folfox protocol 2 Disulfides 2 Cyclophosphamide 2 Cetuximab 2 Aminolevulinic Acid 2 ulixertinib 1 tucatinib 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 tocilizumab 1 tipiracil 1 sotorasib 1 senicapoc 1 romiplostim 1 pirtobrutinib 1 perflutren 1 perampanel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡